Skip to content
Vice President

Tirth Patel joined LHA in 2021, specializing in investor relations and capital markets strategy for healthcare companies. He is responsible for day-to-day client program management, fortifying and expanding relationships across the investment community, attracting new institutional investors and analysts and guiding executive leadership teams on financial communications.

Building upon an academic background in the life sciences, Tirth understands scientific and structural complexities within healthcare to better position companies to capture interest from investors and other stakeholder groups, and differentiate them from the competition. With more than eight years of healthcare investor communications experience, Tirth has guided private and public companies in various healthcare sub-sectors to accomplish their capital markets goals including IPO support, fundraising strategy, scenario planning, crisis communications, and more.  Immediately prior to joining LHA, Tirth was Director of Investor Relations at BioDelivery Sciences (NASDAQ: BDSI), where he led the development of their IR program. Earlier in his career he was a senior professional in the New York offices of Tiberend Strategic Advisors and Edison Group, where he specialized in healthcare-focused investor relations.

Tirth holds a BA in mathematics from Emory University and an MA in Motor Learning & Movement Disorders from Columbia University.

LHA Investor Relations is a leading strategic IR consulting agency. We partner with public and private companies to craft and implement effective, custom-designed IR programs that incorporate industry best practices. We are a leader in investor relations for small-cap companies for over 40 years. We go beyond in implementing IR programs that build trust and transparency between our clients and Wall Street. We support capital market objectives by increasing awareness, managing expectations and enhancing reputations.

Back To Top